ISIN - International Securities Identification Number
  • Services
    • ISIN
    • CUSIP
    • 144A
    • Reg S
    • Equities
    • Bulk Orders
  • ISIN
  • ISIN Directory
  • News
  • Contact
  • Sign In
  • Sign Out
  • Apply for a New Identifier
Sign In Contact Apply for a New Identifier

ISIN Update-DBV Technologies-Viaskin Treatment

October 5, 2015International Securities Identification Number, ISINadmin

ISIN.net Update: DBV Technologies Follow-Up Study of Viaskin® Peanut Shows Significant Increase in Peanut Consumption and Treatment Benefit in Peanut Allergic Children

Findings support Viaskin® Peanut’s efficacy, compliance and safety profile

After 24 months, 80% of treated children respond to Viaskin Peanut 250 microg

12-month response rate in treatment-naïve patients consistent with previously-reported results

On track to start Phase III trial in 4Q 2015

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market:DBVT), a clinical-stage specialty biopharmaceutical company,  today announced that topline findings from the first 12 months of the OLFUS-VIPES study, or OLFUS, support the long-term safety and efficacy of Viaskin Peanut for the treatment of peanut allergy. The Viaskin Peanut patch is the company’s lead product candidate, which is based on epicutaneous immunotherapy (EPIT®), a proprietary technology platform that can deliver biologically active compounds to the immune system through intact skin without allowing compound passage into the blood. OLFUS is an ongoing, open-label, follow-up study to VIPES, the company’s Phase IIb clinical trial with Viaskin Peanut. DBV previously reported positive results from VIPES in September 2014, and is on track to begin a Phase III clinical trial, ‘PEPITES’, with Viaskin Peanut 250 microg in children (ages 4-11) in the fourth quarter of 2015.

Read more: http://www.nasdaq.com/press-release/followup-study-of-viaskin-peanut-shows-significant-increase-in-peanut-consumption-and-treatment-20151005-00015#ixzz3oL64z2GI

courtesy of Nasdaq

Tags: DBV Technologies, ISIn, ISIN Code, ISIN.net, Viaskin

Related Articles

ISIN Update: Construction Manufacturer Prices Dual Tranche Deal

May 7, 2015jay

S&P Sees Extra $6.6 Trillion in Global Corporate Bond Sales

June 20, 2014jay

ISIN Update: Frontline Ltd. Announces Buyback of 4.50 % Convertible Bond Issue

February 13, 2015jay

Resources

  • ISIN
  • CUSIP
  • ISIN Directory
  • News
  • Membership
  • Sign In
  • Rule 144A
  • Regulation S
  • Equity vs Debt Offerings
  • Standard & Poor’s
  • Euroclear
  • Clearstream
  • Frankfurt Stock Exchange
  • SEDOL
  • Bloomberg

Services

  • ISIN
  • CUSIP
  • 144A
  • Reg S
  • Equities
  • Initial Public Offering
  • Bulk Orders

Company Info

  • Contact
  • About Us
  • Partnership Program
  • Privacy Policy
  • Terms of Use
  • Site Map

CONTACT ISIN.NET

Free Consultation: 212-655-9541
Copyright 1999-2021 © ISIN